Uric acid and the state of the intrarenal renin-angiotensin system in humans

Kidney International

Volumn 66, Issue 4, 2004, Pages 1465-1470

  Perlstein, Todd S ^a   Gumieniak, Olga ^b   Hopkins, Paul N ^b   Murphey, Laine J ^b   Brown, Nancy J ^b   Williams, Gordon H ^b   Hollenberg, Norman K ^b   Fisher, Naomi D L ^b  

^a Division of Endocrinology   (United States)

^b NONE

Author keywords

Angiotensin; Kidney; Uric acid; Vascular

Indexed keywords

4 AMINOHIPPURIC ACID; ANGIOTENSIN; HIGH DENSITY LIPOPROTEIN; URIC ACID;

4 AMINOHIPPURIC ACID CLEARANCE; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HYPERTENSION; HYPERURICEMIA; KIDNEY DISEASE; KIDNEY PLASMA FLOW; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PATHOGENESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 4644243534     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00909.x     Document Type: Article

References (33)

1. STEELE TH: Hyperuricemic nephropathies. Nephron 81 (Suppl 1):45-49, 1999
2. JOHNSON RJ, KIVLIGHN SD, KIM YG, et al: Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 33:225-234, 1999
3. MESSERLI FH, FROHLICH ED, DRESLINSKI GR, et al. Serum uric acid in essential hypertension: An indicator of renal vascular involvement. Ann Intern Med 93:817-821, 1980
4. CAPPUCCIO FP, STRAZZULLO P, FARINARO E, et al: Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA 270:354-359, 1993
5. MAZZALI M, HUGHES J, KIM YG, et al: Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38:1101-1106, 2001
6. MAZZALI M, KANELLIS J, HAN L, et al: Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282:F991-F997, 2002
7. NAKAGAWA T, MAZZALI M, KANG DH, et al: Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol 23:2-7, 2003
8. SHOBACK DM, WILLIAMS GH, MOORE TJ, et al: Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension, J Clin Invest 72:2115-2124, 1983
9. HOLLENBERG NK, WILLIAMS GH, BURGER B, et al: Renal blood flow and its response to angiotensin II. An interaction between oral contraceptive agents, sodium intake, and the renin-angiotensin system in healthy young women. Circ Res 38:35-40, 1976
10. HOLLENBERG NK, CHENITZ WR, ADAMS DF, et al: Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 54:34-42, 1974
11. HOLLENBERG NK, WILLIAMS GH, TAUB KJ, et al: Renal vascular response to interruption of the renin-angiotensin system in normal man. Kidney Int 12:285-293, 1977
12. FISHER ND, PRICE DA, LITCHFIELD WR, et al: Renal response to captopril reflects state of local renin system in healthy humans. Kidney Int 56:635-641, 1999
13. HOPKINS PN, LIFTON RP, HOLLENBERG NK, et al: Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 14:199-207, 1996
14. RAJI A, WILLIAMS GH, JEUNEMAITRE X, et al: Insulin resistance in hypertensives: Effect of salt sensitivity, renin status and sodium intake. J Hypertens 19:99-105, 2001
15. JOHNSON RJ, KANG DH, FEIG D, et al: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183-1190, 2003
16. LOMBARDI D, GORDON KL, POLINSKY P, et al: Salt-sensitive hypertension develops after short-term exposure to Angiotensin II. Hypertension 33:1013-1019, 1999
17. WILLIAMS GH, DLUHY RG, LIFTON RP, et al: Non-modulation as an intermediate phenotype in essential hypertension. Hypertension 20:788-796, 1992
18. OSEI SY, PRICE DA, FISHER ND, et al: Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans. Hypertension 33:559-564, 1999
19. HOPKINS PN, HUNT SC, JEUNEMAITRE X, et al: Angiotensinogen genotype affects renal and adrenal responses to angiotensin II in essential hypertension. Circulation 105:1921-1927, 2002
20. FACCHINI F, CHEN YD, HOLLENBECK CB, et al: Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:3008-3011, 1991
21. TER MAATEN JC, VOORBURG A, HEINE RJ, et al: Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects, Clin Sci (Lond) 92:51-58, 1997
22. GANDHI SK, GAINER J, KING D, et al: Gender affects renal vasoconstrictor response to Ang I and Ang II. Hypertension 31:90-96, 1998
23. MILLER JA, ANACTA LA, CATTRAN DC: Impact of gender on the renal response to angiotensin 11. Kidney Int 55:278-285, 1999
24. RAIJ L: Workshop: Hypertension and cardiovascular risk factors: Role of the angiotensin II-nitric oxide interaction. Hypertension 37:767-773, 2001
25. JOSSA F, FARINARO E, PANICO S, et al: Serum uric acid and hypertension: The Olivetti Heart Study. J Hum Hypertens 8:677-681, 1994
26. FEIG DI, JOHNSON RJ: Hyperuricemia in childhood primary hypertension. Hypertension 42:247-252, 2003
27. ISEKI K, OSHIRO S, TOZAWA M, et al: Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 24:691-697, 2001
28. SYRJANEN J, MUSTONEN J, PASTERNACK A: Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 15:34-42, 2000
29. OLLERSTAM A, SALOMONSSON M, PERSSON AE: Reduced rat renal vascular response to angiotensin II after chronic inhibition of nNOS. Acta Physiol Scand 176:245-252, 2002
30. MORIWAKI Y, YAMAMOTO T, TSUTSUMI Z, et al: Effects of angiotensin II infusion on renal excretion of purine bases and oxypurinol. Metabolism 51:893-895, 2002
31. YAMAMOTO T, MORIWAKI Y, TAKAHASHI S, et al: Effect of norepinephrine on the urinary excretion of purine bases and oxypurinol. Metabolism 50:1230-1233, 2001
32. MERVAALA EM, CHENG ZJ, TIKKANEN I, et al: Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes. Hypertension 37:414-418, 2001
33. PUIG JG, TORRES R, RUILOPE LM: AT1 blockers and uric acid metabolism: Are there relevant differences? J Hypertens 20 (Suppl 5):S29-S31, 2002